| P2093 | author name string | Kai Li | |
| | Huanjie Yang | |
| | Qingzhu Yang | |
| | Chen Zhao | |
| | Xuemei Huang | |
| | Xinyuan Li | |
| | Yu Mei | |
| | Lin Jiao | |
| P2860 | cites work | GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. | Q38838244 |
| | The Dual Roles of NRF2 in Cancer. | Q38855289 |
| | Linking Long Noncoding RNA Localization and Function | Q38921242 |
| | Mechanisms of Overcoming Intrinsic Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma through the Redox Modulation. | Q38926773 |
| | Cancer stem cells: The root of tumor recurrence and metastases. | Q39160322 |
| | Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies | Q39390859 |
| | SCF/{beta}-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner. | Q39606140 |
| | Loss of fibulin-5 binding to beta1 integrins inhibits tumor growth by increasing the level of ROS. | Q39733200 |
| | Suppression of Nrf2-driven heme oxygenase-1 enhances the chemosensitivity of lung cancer A549 cells toward cisplatin | Q40051119 |
| | CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. | Q40076996 |
| | Nuclear Long Noncoding RNAs: Key Regulators of Gene Expression | Q49715418 |
| | Decreased expression of the long non-coding RNA SLC7A11-AS1 predicts poor prognosis and promotes tumor growth in gastric cancer | Q49747284 |
| | Antisense lncRNA As-SLC7A11 suppresses epithelial ovarian cancer progression mainly by targeting SLC7A11. | Q50018250 |
| | Somatic mutations of the KEAP1 gene in common solid cancers. | Q53659826 |
| | Long noncoding RNA OCC-1 suppresses cell growth through destabilizing HuR protein in colorectal cancer. | Q55339077 |
| | Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy | Q64073193 |
| | Nrf2 in cancers: A double-edged sword. | Q64891831 |
| | CUL3 and NRF2 mutations confer an NRF2 activation phenotype in a sporadic form of papillary renal cell carcinoma | Q86018422 |
| | NRF2 and the Hallmarks of Cancer | Q88582817 |
| | Cancer statistics, 2019 | Q90941571 |
| | Microenvironmental Regulation of Long Noncoding RNA LINC01133 Promotes Cancer Stem Cell-Like Phenotypic Traits in Triple-Negative Breast Cancers | Q91702604 |
| | BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase | Q24558689 |
| | Eyes wide open: a critical review of sphere-formation as an assay for stem cells | Q24631827 |
| | Redox Modulating NRF2: A Potential Mediator of Cancer Stem Cell Resistance | Q26774916 |
| | Molecular mechanisms of Nrf2 regulation and how these influence chemical modulation for disease intervention | Q26778356 |
| | Reactive oxygen species in cancer stem cells | Q26849216 |
| | Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells | Q28237026 |
| | Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis | Q28242612 |
| | Association of reactive oxygen species levels and radioresistance in cancer stem cells | Q29617812 |
| | Associations Among -TrCP, an E3 Ubiquitin Ligase Receptor, -Catenin, and NF- B in Colorectal Cancer | Q30051055 |
| | Nuclear factor (erythroid-derived 2)-like 2 regulates drug resistance in pancreatic cancer cells | Q33527780 |
| | Preparation of cytoplasmic and nuclear RNA from tissue culture cells | Q34022638 |
| | Methylation of the KEAP1 gene promoter region in human colorectal cancer | Q34156322 |
| | Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy | Q34993085 |
| | Roles of F-box proteins in cancer | Q35012352 |
| | Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis | Q35192383 |
| | The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer | Q35212896 |
| | Long noncoding RNA MALAT-1 enhances stem cell-like phenotypes in pancreatic cancer cells | Q35585395 |
| | Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. | Q36467640 |
| | Long noncoding RNA UPAT promotes colon tumorigenesis by inhibiting degradation of UHRF1. | Q36563349 |
| | Trafficking of the transcription factor Nrf2 to promyelocytic leukemia-nuclear bodies: implications for degradation of NRF2 in the nucleus | Q36850393 |
| | The β-TrCP-FBXW2-SKP2 axis regulates lung cancer cell growth with FBXW2 acting as a tumour suppressor | Q37591349 |
| | Overcoming nucleoside analog chemoresistance of pancreatic cancer: a therapeutic challenge | Q37994505 |
| | Neat1 is a p53-inducible lincRNA essential for transformation suppression | Q38683437 |
| | Linc-DYNC2H1-4 promotes EMT and CSC phenotypes by acting as a sponge of miR-145 in pancreatic cancer cells | Q38697454 |
| | Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade. | Q38739429 |
| | LincRNA-ROR promotes invasion, metastasis and tumor growth in pancreatic cancer through activating ZEB1 pathway | Q38792198 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P921 | main subject | pancreatic cancer | Q212961 |
| P304 | page(s) | 974-985 | |
| P577 | publication date | 2020-01-11 | |
| P1433 | published in | Molecular Therapy. Nucleic acids | Q27724110 |
| P1476 | title | lncRNA SLC7A11-AS1 Promotes Chemoresistance by Blocking SCFβ-TRCP-Mediated Degradation of NRF2 in Pancreatic Cancer | |
| P478 | volume | 19 | |